BetterLife Pharma News and Activities

BetterLife Pharma is a company listed under the stock ticker BETR (CA).

View the org chart displaying its 9 main executives

Most searched biographies at BetterLife Pharma

• Ahmad Doroudian, Chief Executive Officer and Director
• Doug Drysdale, Executive Chairman and Director
• Robert Metcalfe, Director

Popular executive movements at BetterLife Pharma

• Doug Drysdale has joined the company as Executive Chairman and Director  (posted on May 13 2026).

Create your alert
to follow the executive moves at BetterLife Pharma.

BetterLife Pharma has 1,913 competitors including Sanofi (France), Eli Lilly (United States (USA)) and Moderna (United States (USA)).

Popular M&A news in Pharmaceuticals

• Contraline has just announced a $93 Million fundraising (posted on June 3 2026).
• Hims & Hers has acquired Eucalyptus (posted on June 2 2026).
• Apotex has filed its IPO. Its stock ticker will be TSX. (posted on June 2 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Richard Saynor - Chief Executive Officer at Sandoz
• Robert Ford - Chief Executive Officer and Chairman of the Board at Abbott

Learn more about the Pharmaceuticals industry

Press releases by BetterLife Pharma

• Promise of BetterLife’s Non-hallucinogenic LSD (BETR-001) For Treating Mood Disorders Highlighted in Medical Xpress Article - A Better Life Pharma
• https://abetterlifepharma.com/wp-content/uploads/2023/03/2023-03-22-BETR-Medical-Xpress-BETR-001.v2.pdf
• BetterLife Secures Additional Mitacs Funding in Collaboration with Carleton University Research Team for BETR-001 Preclinical Depression Studies - A Better Life Pharma
• BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression - A Better Life Pharma
• https://abetterlifepharma.com/wp-content/uploads/2022/06/2022-04-06-BETR-Anti-depressant-BETR001.pdf
• BetterLife Receives FDA Response On Its Pre-IND Application For Major Depressive Disorder (MDD) Treatment With BETR-001 - A Better Life Pharma
• Press Release: BetterLife Pharma completes C$10M acquisition of LSD derivative owner Transcend Biodyanmics LLC | Cannabis Law Report
• Betterlife Pharma Inc. (OTCMKTS: BETRF) Receives First Data Set for Its Flagships LSD-Derivative Compound In Depression Treatment
• BetterLife’s BETR-001 Demonstrates BETR-001 Anti-depressant Activity in Preclinical Models of Depression - A Better Life Pharma
• https://abetterlifepharma.com/wp-content/uploads/2022/04/2022-04-06-BETR-Anti-depressant-BETR001.pdf
• View more press releases Close

Social media about BetterLife Pharma

• BetterLife Pharma on Wikipedia, Google News & Yahoo Finance
• BetterLife Pharma on LinkedIn, X (Twitter) & YouTube